Business Context and Reporting Period
Ainos, Inc. (AIMD) filed a Form 8-K on July 15, 2024, regarding a deficiency notice from The Nasdaq Stock Market LLC. The Company is incorporated in Texas and its common stock and warrants trade on The Nasdaq Capital Market.
Key Financial Metrics
This filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on listing compliance status.
Material Changes and Listing Status
On July 15, 2024, the Company received a deficiency letter from Nasdaq stating that its common stock closing bid price has been below the minimum $1.00 per share requirement for the last 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). The stock continues to trade under the symbol "AIMD" with no immediate effect on listing.
Outlook, Risks, and Compliance Timeline
- Compliance Period: The Company has 180 calendar days, until January 13, 2025, to regain compliance.
- Compliance Criteria: To regain compliance, the closing bid price must be $1.00 or more for a minimum of 10 consecutive business days before the deadline.
- Extension Possibility: If the Company fails to meet the requirement by January 13, 2025, it may be eligible for an additional 180-day period if it meets other initial listing standards (excluding the bid price) and notifies Nasdaq of its intent to cure.
- Risks: There is no assurance the Company will regain compliance. Failure to cure the deficiency could result in delisting.
- Management Action: The Company intends to monitor the stock price and may consider available options to regain compliance.
Investor Verification Checklist
- Verify the current closing bid price of AIMD to assess proximity to the $1.00 threshold.
- Monitor the Company's stock price for 10 consecutive days of trading at or above $1.00 to confirm compliance.
- Review future filings for any announcements regarding reverse stock splits or other capital structure changes intended to address the deficiency.
- Check for any subsequent notices from Nasdaq regarding the denial of a second compliance period or delisting proceedings.